Prevalence of antibiotic resistance in Escherichia coli: Overview of geographical, temporal, and methodological variations

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 2, 2007, Pages 83-90

  Erb, A ^a   Sturmer T ^a   Marre, R ^c   Brenner, H ^a,b  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; TRIMETHOPRIM;

ANIMAL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM DETECTION; DATA BASE; ESCHERICHIA COLI; EUROPE; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; MEDLINE; METHODOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RESEARCH; SAMPLING; SOUTH AMERICA; SPAIN; STANDARDIZATION; SYSTEMATIC REVIEW; TURKEY (BIRD); UNITED STATES; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; URINARY TRACT INFECTIONS;

EID: 33846785045     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-006-0248-2     Document Type: Article

References (41)

1. Dunne EF, Fey PD, Kludt P, Reporter R, Mostashari F, Shillam P, Wicklund J, Miller C, Holland B, Stamey K, Barrett TJ, Rasheed LK et al (2000) Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA 284:3151-3156
2. Kollef MH, Fraser VJ (2001) Antibiotic resistance in the intensive care unit. Ann Intern Med 134:298-314
3. Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP, Heine H, Monnickendam MA, Barker KF, James D, George RC (2000) Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br Med J 320:213-216
4. Tenover FC, Hughes JM (1996) The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA 275:300-304
5. deMan P, Verhoeven BAN, Verburgh HA, Vos MC, van den Anker JN (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973-978
6. Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M (2003) Antibiotic resistance - the interplay between antibiotic use in animals and human beings. Lancet Infect Dis 3:47-51
7. Bartoloni A, Bartalesi F, Mantella A, Dell'Amico E, Roselli M, Strohmeyer M, Barahona HG, Barron VP, Paradisi F, Rossolini GM (2004) High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption. J Infect Dis 189:1291-1294
8. Lester SC, del Pilar Pla M, Wang F, Perez Schael I, Jiang H, O'Brien TF (1990) The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med 323:285-289
9. Kahlmeter G, ECO.SENS (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51:69-76
10. Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 50:59-69
11. von Baum H, Marre R (2005) Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol 295:503-511
12. Bonten M, Stobberingh E, Philips J, Houben A (1992) Antibiotic resistance of Escherichia coli in fecal samples of healthy people in two different areas in an industrialized country. Infection 20:258-262
13. Calva JJ, Sifuentes-Osornio J, Ceron C (1996) Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico. Antimicrob Agents Chemother 40:1699-1702
14. Dominguez E, Zarazaga M, Saenz Y, Brinas L, Torres C (2002) Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain. Microb Drug Resist 8:321-327
15. Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, Llovet T, Ruiz-Bremon A (1999) Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 43:2736-2741
16. Gulay Z, Bicmen M, Amyes SG, Yulug N (2002) Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers. J Chemother 12:208-215
17. London N, Nijsten R, van der Bogaard A, Stobberingh E (1994) Carriage of antibiotic-resistant Escherichia coli by healthy volunteers during a 15-week period. Infection 22:187-192
18. Stürmer T, Erb A, Marre R, Brenner H (2004) Prevalence and determinants of colonisation with antibiotic-resistant Escherichia coli in unselected patients attending general practitioners in Germany. Pharmacoepidemiol Drug Saf 13:303-308
19. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (2000) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359-365
20. Brumfitt W, Faiers MC, Reeves DS, Datta N (1971) Antibiotic-resistant Escherichia coli causing urinary-tract infection in general practice: relation to faecal flora. Lancet 1:315-317
21. Gales AC, Jones RN, Gordon KA, Sader HS, Wilke WW, Beach ML, Pfaller MA, Doern GV (2000) Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother 45:295-303
22. Gupta K, Sahm DF, Mayfield D, Stamm WE (2001) Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 33:89-94
23. Huovinen P, Toivanen P (1980) Trimethoprim resistance in Finland after five years' use of plain trimethoprim. Br Med J 280:72-74
24. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF (2002) Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 46:2540-2545
25. Vorland LH, Carlson K, Aalen O (1985) Antibiotic resistance and small R plasmids among Escherichia coli isolates from outpatient urinary tract infections in northern Norway. Antimicrob Agents Chemother 27:107-113
26. Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ (2000) A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother 44:1089-1092
27. Zhanel GG, Hisanaga TL, Laing NM, Decorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA, for the NAUTICA Group, Hoban DJ (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 27:468-475
28. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J (2000) Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 30:454-460
29. Oteo J, Lazaro E, de Abajo FJ, Baquero F, Campos J, Spanish members of EARSS (2005) Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 11:546-553
30. Reynolds R, Potz N, Colman M, Williams A, Livermore D, MacGowan A, and the BSAC extended working party on bacteraemia resistance surveillance (2004) Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. J Antimicrob Chemother 53:1018-1032
31. Shannon KP, French GL (2002) Antibiotic resistance: effect of different criteria for classifying isolates as duplicates on apparent resistance frequencies. J Antimicrob Chemother 49:201-204
32. Kresken M, Hafner D (1999) Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study group bacterial resistance of the Paul-Ehrlich-society for chemotherapy. Infection 27 (Suppl 2):2-8
33. Gould IM (2000) Towards a common susceptibility testing method. J Antimicrob Chemother 45:757-762
34. Chulain MN, Murray AM, Corbett-Feeney G, Cormican M (2005) Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 174:6-9
35. Bartolini A, Pallecchi L, Benedetti M, Fernandez C, Vallejos Y, Guzman E, Villagran AL, Mantella A, Lucchetti C, Bartalesi F, Strohmeyer M, Bechini A, et al (2006) Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis 12:907-913
36. Ishii Y, Alba J, Kimura S, Yamaguchi K (2006) Evaluation of antimicrobial activity of beta-lactam antibiotics by E test against clinical isolates from 100 medical centers in Japan (2004). Diagn Microbiol Infect Dis 55:143-148
37. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657-686
38. Pitout JD, Hanson ND, Church DL, Laupland KB (2004) Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clin Infect Dis 38:1736-1741
39. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089-1094
40. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R (2004) Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23:163-167
41. Davison HC, Low JC, Woolhouse MEJ (2000) What is antibiotic resistance and how can we measure it? Trends Microbiol 8:554-559